Robeco Institutional Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,792
Closed -$589K 1082
2023
Q1
$589K Buy
9,792
+1,850
+23% +$148K ﹤0.01% 838
2022
Q4
$583K Buy
7,942
+6,965
+713% +$524K ﹤0.01% 823
2022
Q3
$74K Sell
977
-1,345
-58% -$105K ﹤0.01% 898
2022
Q2
$161K Hold
2,322
﹤0.01% 845
2022
Q1
$192K Buy
+2,322
New +$171K ﹤0.01% 847
2021
Q4
Sell
-514
Closed -$60K 938
2021
Q3
$60K Sell
514
-12,231
-96% -$1.85M ﹤0.01% 898
2021
Q2
$2.83M Sell
12,745
-7,442
-37% -$1.45M 0.01% 658
2021
Q1
$2.67M Buy
20,187
+4,281
+27% +$677K 0.01% 631
2020
Q4
$2.75M Buy
+15,906
New +$2.18M 0.01% 628

Other funds holding NVCR